PMID: 2460297Nov 1, 1988

Survival experience following Nd:YAG laser photoresection for primary bronchogenic carcinoma

S J DesaiM Ahmad


We followed the course of 47 consecutive patients with inoperable primary bronchogenic carcinoma who underwent palliative neodymium-yttrium-aluminum-garnet laser photoresection (YPR) between September 1983 and September 1986. Of these 47, 35 (74.5 percent) underwent both radiation therapy (XRT) and YPR. The survival of these 35 patients (median survival, 304 days) was compared with that of 58 who underwent only palliative palliative XRT (median survival, 253 days) from 1981 to 1983, when YPR was not yet available at our institution. There was no significant difference in overall survival (p = 0.17). A significant increase in survival (p = 0.04) was seen in 15 patients who underwent emergency palliative YPR as the initial therapeutic intervention compared with 11 patients who received emergency palliative XRT but would have received YPR had it been available at that time. A trend toward increased survival was also shown in patients who underwent endobronchial radiation therapy in addition to YPR and XRT.


Jul 1, 1979·Radiology·R G Slawson, R M Scott
Jan 1, 1985·Cleveland Clinic Quarterly·A C MehtaJ O'Donnell
Oct 1, 1984·Chest·A Arabian, S V Spagnolo


Apr 29, 2006·Current Infectious Disease Reports·Ravindra M Mehta, Michael Cutaia
Feb 19, 2004·Cryobiology·M O MaiwandJ E Beeson
Apr 17, 1999·Clinics in Chest Medicine·J F Turner, K P Wang
May 1, 2004·Photodiagnosis and Photodynamic Therapy·Harubumi KatoTetsuya Okunaka
Mar 10, 2001·The New England Journal of Medicine·L M Seijo, D H Sterman
Jul 27, 2001·Current Opinion in Pulmonary Medicine·A L ChanKen Y Yoneda
Jun 14, 2003·Current Opinion in Pulmonary Medicine·Andrew L ChanT E Albertson
Apr 1, 1990·Australian and New Zealand Journal of Medicine·R J PierceF J Daniel
Jun 10, 2004·American Journal of Respiratory and Critical Care Medicine·Armin ErnstAtul C Mehta
Mar 4, 2014·Lasers in Medical Science·John J SquiersJ Michael DiMaio
Jan 1, 1993·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·H D BeckerP Drings
Jun 11, 2005·Chest·G AsimakopoulosM O Maiwand
May 6, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Firuz CelikogluEugene P Goldberg
May 1, 1995·Current Problems in Cancer·K A Yeh, M Goldberg
May 1, 1996·Current Problems in Cancer·M Goldberg
Oct 24, 2009·Internal Medicine Journal·J P WilliamsonP R Eastwood
Dec 20, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Firuz CelikogluEugene P Goldberg
Apr 18, 2003·Chest Surgery Clinics of North America·Michael Unger
Jul 1, 2011·The Korean Journal of Internal Medicine·Seon-Heui LeeKwang-Joo Park
Apr 3, 2004·Technology in Cancer Research & Treatment·M O Maiwand, G Asimakopoulos
Aug 1, 1990·Chest·A L ChanR P Allen
Jan 24, 2014·Expert Review of Respiratory Medicine·Herve DutauPhilippe Astoul
May 13, 2005·Journal of Intensive Care Medicine·Momen M Wahidi, Armin Ernst
May 16, 2007·The American Journal of Hospice & Palliative Care·Andrew R Haas
Jun 13, 2020·Thoracic Cancer·Hoon Sik ChoiKi Mun Kang
Mar 1, 1997·Postgraduate Medicine·D E Midthun
Aug 3, 2001·Cancer Control : Journal of the Moffitt Cancer Center·M J Simoff
Jun 14, 2019·Annals of the American Thoracic Society·Udit ChaddhaSeptimiu Murgu

Related Concepts

Bronchogenic Carcinoma
Combined Modality Therapy
Malignant Neoplasm of Lung
Palliative Surgery
Retrospective Studies
Laser Surgery

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.